Cargando…
Cannabinoid receptor agonist protects cultured dopaminergic neurons from the death by the proteasomal dysfunction
Cannabinoids have been proposed to possess neuroprotective properties; though their mechanism of action remains contentious, they are posited to prevent neurodegenerative disorders, including Parkinson's disease, the pathogenesis of which has not been established. Recent studies have demonstrat...
Autores principales: | Jeon, Posung, Yang, Sungjun, Jeong, Hojoong, Kim, Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association of Anatomists
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3145842/ https://www.ncbi.nlm.nih.gov/pubmed/21829757 http://dx.doi.org/10.5115/acb.2011.44.2.135 |
Ejemplares similares
-
Age-dependent neuroprotective effect of an SK3 channel agonist on excitotoxity to dopaminergic neurons in organotypic culture
por: Maldonado, Oscar, et al.
Publicado: (2020) -
CB(2) Receptor Agonists Protect Human Dopaminergic Neurons against Damage from HIV-1 gp120
por: Hu, Shuxian, et al.
Publicado: (2013) -
Early-onset impairment of the ubiquitin-proteasome system in dopaminergic neurons caused by α-synuclein
por: McKinnon, Chris, et al.
Publicado: (2020) -
Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG‐018
por: Finlay, David B., et al.
Publicado: (2022) -
Necrostatin-1 protection of dopaminergic neurons
por: Wu, Jing-ru, et al.
Publicado: (2015)